Dyee Capital is an early and growth stage venture capital firm that also engages in private equity opportunities. The firm focuses its investments across diverse sectors including information services, consumption, medical and healthcare, consumer discretionary, financial services, information technology, raw materials, industrials, and TMT.
100% of their portfolio is in Biotech & Life Sciences.
Portfolio
2
Fund Size
—
Top Stage
Unknown
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Degron Therapeutics | Series A | $22M | Jun 2022 |
| IIONOVA Life Science | Unknown | $100M | Aug 2021 |
Top Co-Investors
Med-Fine Capital1 shared
Yuanbio Venture Capital1 shared
Last updated: 4 May 2026